J. L. Bainbridge & Co., Inc. Eli Lilly & CO Transaction History
J. L. Bainbridge & Co., Inc.
- $942 Million
- Q1 2024
A detailed history of J. L. Bainbridge & Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, J. L. Bainbridge & Co., Inc. holds 3,430 shares of LLY stock, worth $3.11 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,430
Previous 3,429
0.03%
Holding current value
$3.11 Million
Previous $2 Million
33.53%
% of portfolio
0.28%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
3,719Shares Held
738MCall Options Held
7.09MPut Options Held
7.24M-
Lilly Endowment Inc Indianapolis, IN98.9MShares$89.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$65.9 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$59.1 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$46.6 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$31 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $860B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...